Literature DB >> 15670387

Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100beta.

David N Loy1, Angela E Sroufe, Jennifer L Pelt, Darlene A Burke, Qi-Lin Cao, Jason F Talbott, Scott R Whittemore.   

Abstract

OBJECTIVE: We evaluated whether serum levels of neuron-specific enolase (NSE) and S-100beta protein are biomarkers for traumatic injury in an animal model of spinal cord injury (SCI).
METHODS: Enzyme-linked immunosorbent assay serum measurements of NSE and S-100beta and assays of serum protein were compared at 6 and 24 hours after a graded contusive SCI (150 or 200 kdyn IH impactor injury (Infinite Horizons, L.L.C., Lexington, KY) or sham laminectomy at T9 in 30 female Sprague-Dawley rats. Serum from control animals was also analyzed.
RESULTS: Increases in serum levels of NSE were observed for 200-kdyn (3.1-fold, P < 0.001) and 150-kdyn (2.3-fold, P < 0.001) injury groups at 6 hours after injury, which decreased by 73.7% (P < 0.001) and 65.2% (P < 0.001) at 24 hours after SCI, respectively; the levels were still greater than in sham animals (P < 0.001, P = 0.001). The 200- and 150-kdyn injury groups were not different at either time point. S-100beta serum levels increased at 6 hours in the 200-kdyn injury group (P < 0.05), and no differences from sham levels were seen at 24 hours. No differences in total protein concentrations were observed between the injury and control groups.
CONCLUSION: Present data suggest that NSE and S-100beta serum levels may be useful experimental tools for the acute measurement of tissue loss after SCI. Despite significant shortcomings, NSE and S-100beta serum measurements in acute SCI patients with clinically defined functional deficits should allow comparisons with well-characterized SCI animal models. Future efforts to develop biomarkers that predict functional outcomes in the acute phase should focus on axon-specific proteins as markers of secondary axonal loss and regeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670387     DOI: 10.1227/01.neu.0000148906.83616.d2

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  15 in total

1.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

2.  Proteomic and phosphoproteomic analyses of the soluble fraction following acute spinal cord contusion in rats.

Authors:  Anshu Chen; Melanie L McEwen; Shixin Sun; Rangaswamyrao Ravikumar; Joe E Springer
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

3.  Nanoparticle Estrogen in Rat Spinal Cord Injury Elicits Rapid Anti-Inflammatory Effects in Plasma, Cerebrospinal Fluid, and Tissue.

Authors:  April Cox; Abhay Varma; John Barry; Alexey Vertegel; Naren Banik
Journal:  J Neurotrauma       Date:  2015-06-25       Impact factor: 5.269

4.  Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury.

Authors:  Ahmed Moghieb; Helen M Bramlett; Jyotirmoy H Das; Zhihui Yang; Tyler Selig; Richard A Yost; Michael S Wang; W Dalton Dietrich; Kevin K W Wang
Journal:  Mol Cell Proteomics       Date:  2016-05-05       Impact factor: 5.911

Review 5.  The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood.

Authors:  C H Hulme; S J Brown; H R Fuller; J Riddell; A Osman; J Chowdhury; N Kumar; W E Johnson; K T Wright
Journal:  Spinal Cord       Date:  2016-12-20       Impact factor: 2.772

Review 6.  Neurochemical biomarkers in spinal cord injury.

Authors:  Brian K Kwon; Ona Bloom; Ina-Beate Wanner; Armin Curt; Jan M Schwab; James Fawcett; Kevin K Wang
Journal:  Spinal Cord       Date:  2019-07-04       Impact factor: 2.772

7.  Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury.

Authors:  Aslan Guzel; Uygur Er; Mehmet Tatli; Ufuk Aluclu; Umit Ozkan; Yucel Duzenli; Omer Satici; Ebru Guzel; Serdar Kemaloglu; Adnan Ceviz; Abdurrahman Kaplan
Journal:  Neurosurg Rev       Date:  2008-06-17       Impact factor: 3.042

Review 8.  The Next Generation of Biomarker Research in Spinal Cord Injury.

Authors:  Elke Ydens; Ilse Palmers; Sven Hendrix; Veerle Somers
Journal:  Mol Neurobiol       Date:  2016-02-05       Impact factor: 5.590

9.  Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats.

Authors:  Joanna M Lubieniecka; Femke Streijger; Jae H T Lee; Nikolay Stoynov; Jie Liu; Randy Mottus; Tom Pfeifer; Brian K Kwon; Jens R Coorssen; Leonard J Foster; Thomas A Grigliatti; Wolfram Tetzlaff
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

10.  The role of markers of inflammation in traumatic brain injury.

Authors:  Thomas Woodcock; Maria Cristina Morganti-Kossmann
Journal:  Front Neurol       Date:  2013-03-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.